Hereditary haemorrhagic telangiectasia (HHT): negotiating between the Scylla of bleeding and Charybdis of thrombosis.
Ghosh
Kanjaksha
K
Ghosh
Kinjalka
K
D000328:Adult; D000933:Antifibrinolytic Agents / Q000009:adverse effects*; D002312:Cardiomyopathy, Hypertrophic / Q000097:blood / Q000150:complications*; D003082:Colectomy; D003125:Colostomy; D004621:Embolization, Therapeutic / Q000009:adverse effects; D004844:Epistaxis / Q000209:etiology; D017707:Erythrocyte Transfusion; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006470:Hemorrhage / Q000097:blood / Q000209:etiology* / Q000628:therapy; D006489:Hemostatic Techniques / Q000009:adverse effects*; D006801:Humans; D007044:Hysterectomy; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000097:blood / Q000150:complications* / Q000628:therapy; D014148:Tranexamic Acid / Q000009:adverse effects; D020246:Venous Thrombosis / Q000097:blood / Q000139:chemically induced* / Q000628:therapy
D000933:Antifibrinolytic Agents; D004997:Ethinyl Estradiol; D014148:Tranexamic Acid